# Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

> **NCT01298102** · PHASE4 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 185 (actual)

## Conditions studied

- Decreased Immunologic Activity [PE]
- Influenza
- Rejection

## Interventions

- **BIOLOGICAL:** Influenza A/H1N1 2009-AS03 adjuvanted (Pandemrix)

## Key facts

- **NCT ID:** NCT01298102
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298102, "Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01298102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*